Microdosing Tirzepatide Rx
A low-dose GLP-1 approach designed to work in sync with the body, which may help minimize side effects, quiet cravings, and support moderate weight loss.
-
- Monthly, 2-mo, and 4-mo plans
- Starting price applies to 4-mo plans
- US-licensed pharmacies
- Pause or cancel anytime
Frequently asked questions
Microdosing Tirzepatide uses lower amounts than standard dosing. Your provider will guide your plan and help you understand how to measure your dose correctly. The goal is the lowest dose that may deliver a noticeable effect while minimizing side effects.
Yes. If your goals change or you need more support, your provider can help determine whether a full-dose GLP-1 prescription may be a better fit.
No. Microdosing Tirzepatide uses lower amounts than standard GLP-1 dosing and is designed for adults seeking a gentler, clinician-guided approach.
Microdosing Tirzepatide is self-administered according to your provider-guided titration schedule. If prescribed, a US-licensed provider will provide a tailored dosage schedule and specific treatment instructions with your care plan.
Important safety information and common side effects
Microdosing Tirzepatide medication may include glycine, an amino acid intended to support cellular function and metabolism. Microdosing Tirzepatide should be used with a reduced-calorie meal plan and increased physical activity.
Do not use with other GLP-1 receptor agonist medications, or any other products containing GLP-1s.
Side effects
Microdosing Tirzepatide is a low-dose injectable GLP-1 (Tirzepatide) prescription.
The most common side effects of Tirzepatide-based medications are nausea and constipation. Other gastrointestinal issues like indigestion, vomiting, and diarrhea may occur, though they are less common. The side effects you may experience will vary depending on your prescribed dose, your medical history, and your lifestyle choices.
Common side effects normally go away on their own within a few days or up to 2-3 weeks. Read our blog for more tips on how to manage GLP-1 side effects. If you find that any side effects persist for longer than this or get worse over time, stop taking your medication and contact your provider as soon as possible.
For a full list of side effects, please review the Mayo Clinic’s Tirzepatide resources.
Potential drug interactions
Tirzepatide may make oral contraceptives less effective. If you’re taking an oral contraceptive, ask your provider about potential alternatives before starting Microdosing Tirzepatide, or switch to a non-oral contraceptive.
Tell your healthcare provider about all the medications you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Tell your healthcare provider if you are taking any medications to treat diabetes, including sylfonylureas or insulin.
Other important safety information
Do not use GLP-1s if you have a personal or family history of medullary thyroid carcinoma (MTC), multiple endocrine neoplasia syndrome 2 (MEN2), or pancreatitis. Do not use GLP-1s if you are pregnant or breastfeeding, or planning to become pregnant or breastfeed.
Though rare, allergic reactions to GLP-1 medications are possible. If you notice any shortness of breath or swelling around your face, tongue, or throat after using GLP-1s, stop using the medication immediately and contact emergency services right away.
As with any prescription medicine, the dose prescribed is for you and you alone. Do not, under any circumstances, allow anyone else to use your prescription.
Tell your healthcare provider about all the medications you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Tell your healthcare provider if you are taking any medications to treat diabetes, including sylfonylureas or insulin.
Note: The above statements have not been evaluated by the Food and Drug Administration. This product alone is not intended to diagnose, treat, cure, or prevent any disease. Please consult a medical professional to determine whether or not Microdosing Tirzepatide is appropriate for you.
Disclaimer
What is Microdosing Tirzepatide?
(tir-ZEP-uh-tide)Some people do not need the most aggressive GLP-1 option. They need help getting unstuck. Microdosing Tirzepatide uses lower amounts than standard dosing, potentially supporting moderate weight loss for those dealing with stubborn weight, plateaus, or food noise.1 2
Unlike single-pathway GLP-1s, Tirzepatide works on two pathways at once: GIP and GLP-1. If GLP-1 acts like headphones that help muffle cravings, Tirzepatide’s added GIP pathway may work more like noise cancellation, helping turn down the food-noise in the background.2
80% notice weight loss4
How Microdosing Tirzepatide works
30 Days
3 Months
6 Months
1 Year and Beyond
Disclaimer
Our GLP-1 research is shaping what comes next
GLP-1 care that starts with you
$159/month
Applies to 4-month plan billed in full
What’s included
-
Personalized, clinician-guided plan
-
Monthly, 2-month, and 4-month plans
-
Dispensed by US-licensed compounding pharmacy
-
Unlimited protocol adjustments and messaging
-
Ongoing support and check-ins
-
Pause or cancel anytime
-
Backed by our in-house Stanford PhD-led team
Clinically studied
The science of Microdosing Tirzepatide
Recent studies have begun exploring lower doses for gentler, broader weight support.2 In studies, Tirzepatide supported a favorable shift in body composition and more fat loss with preserved lean mass, while modulating inflammatory pathways and supporting cardiovascular health.1 3 5
Choosing how you age starts here
Connect with a clinician
Get your discreet shipment
Receive continuous support
Disclaimer
Weight, personalized.
Frequently asked questions
Tirzepatide works on two pathways, GIP and GLP-1, that are involved in appetite, fullness, and metabolic response.¹ ² Microdosing uses lower amounts than standard dosing, with provider-guided adjustments over time aimed at the lowest dose that helps you hit your goals while minimizing side effects.
This is one of the more genuinely exciting parts of the GLP-1 story. Research shows GLP-1 receptor agonists lower CRP, a key inflammation marker, through mechanisms that go beyond weight loss alone.⁵ In clinical studies, Tirzepatide has been shown to reduce CRP, IL-6, and other inflammatory markers independent of weight loss.³ ⁵ Most of this evidence comes from standard weight loss doses, but the underlying biology and real-world data is a reasonable basis for interest in a lower-dose approach.
Microdosing is not designed to match full-dose GLP-1 weight loss. Full-dose GLP-1s are dosed to maximize weight loss; Microdosing is dosed to find the minimum amount that may deliver metabolic and craving-related benefits while minimizing side effects.
In our own user data, average weight loss by 6 months has been around 10 lbs.
Most GLP-1 medications work on one pathway. Tirzepatide works on two, GIP and GLP-1, that may help influence appetite, fullness, blood sugar, and how the body handles fat.²
Microdosing Tirzepatide is taken once weekly by subcutaneous injection, only as prescribed by your provider. If approved, you will receive a personalized dosing schedule from your provider based on your unique health history.